Content Type: Research Publications

Share of Sales Subject to Medicare Inflation Rebates and Price Increases of Top-Selling Drugs

March 6, 2026

Revenue, Patents, and New Generic Competition for Prescription Drugs in the USA

March 6, 2026

Prescription Drug Method-Of-Use Patent Protection, 1991-2018

March 6, 2026

Insurer Exits After the Inflation Reduction Act Part D Redesign

March 6, 2026

Health Technology Assessment, Again: A Transparent, Evidence-Based Approach for CMS Drug Price Negotiations

March 6, 2026

Expansion of 340B Disproportionate Share Hospitals in the United States From 2010 to 2022

March 6, 2026

Differences Between Trial Populations and Approved Label Populations of New Drugs in the United States and Europe (2012 to 2023): A Cross-Sectional Study

March 6, 2026

Community Pharmacy Turnover and Context of Openings and Closings By Ownership Type

March 6, 2026

Health Professional Students’ Knowledge About FDA Drug and Medical Device Regulation

March 6, 2026

Estimating Costs of Market Exclusivity Extensions for 4 Top-Selling Prescription Drugs in the US

March 6, 2026

Trends in Time to Withdrawal and Full Approval of Accelerated Approval Cancer Drug Indications (1992-2024)

March 6, 2026

Costs of Extending the Small Molecule Exemption Period in Medicare Drug Price Negotiation

March 6, 2026